Both formulations are administered as intramuscular injections, usually weekly, as part of a medically-supervised weight loss protocol that includes caloric restriction and, increasingly, GLP-1 receptor agonist therapy like semaglutide or tirzepatide
Genetic Predisposition and Peptide Pathway Sensitivity Genetic variation in GLP-1 receptor signaling (GLP1R rs6923761), glucose-dependent insulinotropic polypeptide receptor pathways (GIPR rs1800437), and appetite regulation (MC4R rs17782313, FTO rs9939609) may influence individual dose tolerance and efficacy
Costs and approval requirements can vary widely depending on the plan
With the growing conversation around obesity, theres also a controversy bubbling under the surface ready to overflow
Your age, activity level, and physical health may also be factors